Regeneron Pharmaceuticals, Inc.

Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
195,674
Value ($000)
121,893
Weight
0.5%
2019 Q3 - 2026 Q2 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).